Dinesh Dua to Head Pharmexcil
The Pharmaceuticals Export Promotion Council of India (Pharmexcil) has announced that Mr. Dinesh Dua, CEO & Director of Nectar Lifesciences Ltd. has been elevated to the position of Chairman of the council during a committee meeting held on June 18, 2018 at Hyderabad. He will have a tenure of two years (2018-2020). Mr. Dua was serving as the Vice Chairman of council for the past 2 years.
Looking for chemical products? Let suppliers reach out to you!
You May Interested In
β-Nicotinamide Adenine Dinucleotide High Quality NAD+ CAS 53-84-9 Exclusive Production Factory CAS NO.53-84-9
$75/UNIT FOB
2026-07-14
-
Life Sciences Industry Overview
The coverage spans the global life sciences industry across pharmaceuticals and food & nutrition, tracking the shift from lowest-cost sourcing to supply continuity, quality, and risk management, along with product trends and the growing edge of differentiated, globally capable players.Published in: June.2026
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Merck to Lay Off 150 Workers at US Gardasil Plant Amid Sales Weakness
-
Roche Keeps German Diagnostics Investment
-
Pfizer Warns Germany Over Drug-Pricing Policy
-
India Raises Cancer Drug Price Caps by 50%
-
Merck and Eisai Halt Late-Stage Trial for Liver Cancer Therapy
-
U.S. Health Chief Says No Evidence Linking Tylenol to Autism
-
Lilly Eyes Fast-Track Approval for Oral Weight-Loss Drug in U.S.
-
Platinum Chemotherapy Shortages Expose the Fragility of Essential API Supply
-
Lilly’s U.S. API Investment Highlights a New Phase of Pharma Supply Localization
-
Strides Pharma Reports Strong Q2 as Net Profit Surges 82%
Recommend Reading
-
Pfizer Sues Metsera and Novo Nordisk Over Rival Obesity Drug Strategy
-
India Strengthens Drug Approval Oversight with Expanded CDSCO Powers
-
Pfizer Seen Holding Strategic Edge in Bidding Battle for Metsera
-
Cipla CEO Calls Tirzepatide a High-Science Product with Strong Market Outlook
-
Novo Nordisk Enters High-Stakes Bidding War with Pfizer for Metsera
-
Cost Pulls Up March PC Market Performance
-
Favorable Factors Boost Shandong Cyclohexanone Market Prices by Over 30% in March
-
Supply Disruptions Repeatedly Resonate, Lithium Carbonate Experiences Sharp Fluctuations
-
Strong Cost Support Drives Robust Rise in Anhydrous Hydrogen Fluoride Market
-
Both Supply and Demand Tightening Drives Butadiene Prices Up Sharply in March